What Your $10 Bought in Southern Cross II's IPO

D. Boral Capital, a boutique bank, is pleased to announce — in an actual press release — that it acted as sole bookrunner to Southern Cross Acquisition II Corp. in an initial public offering that raised $76.5 million on Nasdaq. Banks publish those releases for marketing, not as market analysis. But the machine behind this one is worth understanding, because of what $10 bought you.

Southern Cross II is a blank-check company, incorporated in the Cayman Islands in September 2025, with no operations, no revenue, and no product. Its entire job is to find a business to buy within 12 months and merge into it. To fund that search it sold 7,652,630 units at $10.00 apiece for gross proceeds of $76,526,300, with the closing announced August 27, 2026.

Each unit is three securities bolted together: one ordinary share, one warrant to buy another share at $11.50, and one right to receive one-fourth of an ordinary share if and when a deal closes.

Here is the weird part. The ordinary share is not really a share of anything yet. Behind it sits a trust account holding roughly $76.7 million — about $10.025 per public unit — which is a penny or two more than the $10 you handed over. So a unit buyer is not owning a company. The buyer is holding a money-market claim plus two free options, priced to sit still like a savings account for as long as nothing happens. That is why the units trade at about $10.01 on Nasdaq, which is all the market is saying right now: cash, with options the market currently values at roughly nothing.

The options are the entire point. The warrant is a five-year call on an ordinary share at $11.50. The right becomes a quarter-share if a deal closes. Neither has any value until the "initial business combination," and the clock is short — the company has 12 months from closing to find one — because if no deal happens in time, the company liquidates, public shareholders get their pro-rata slice of the trust, and the warrants and rights expire worthless.

So the downside is partly engineered away: buy at $10, and if the search fails you get about your $10 back (a bit above, at least at the start, less liquidation costs). The upside is entirely "they find a deal, and it's a good one." And the middle is dilution — which is where the people who built this machine get paid.

Meet the founders. The chairwoman and CEO is Ally Tong Zhang, based in New Zealand; the CFO, Xin Wang, is in China; the three independent directors sit in Hong Kong and Singapore. Through the sponsor, they paid $25,000 for 2,875,000 founder shares — the classic SPAC promote, arranged so the founders would end up with about 20% of the company, and, after the offering was cut in size in August, closer to a quarter of the register once the private and representative shares are counted. Even at an ordinary $10 a share after a deal, that is paper worth tens of millions of dollars against a $25,000 outlay.

The sponsor also bought 224,932 private units at $10.00 — $2,249,320 — in a private placement that closed with the IPO. And here is the part that makes the incentives legible. If no deal ever happens, the proceeds of that private placement go to the public shareholders, not the sponsor, and the founder shares and private shares get nothing in the liquidation. So the sponsor's own $2.3 million is only converted into a payoff by closing a deal — the quicker and more certain the deal, the better for the sponsor, whatever the deal is worth to you. The prospectus says this out loud. The founder shares "could create an incentive our founders to complete any transaction, regardless of its ultimate value," and the founders "are likely to make a substantial profit on their investment in us" even if the deal "causes the trading price of our ordinary shares to decline materially."

Your counterweight is the redemption right: at each merger vote you can cash out at roughly the trust value instead of tagging along. That right is doing the heavy lifting in today's market, where a typical merger now sees about 96% of the trust redeemed out — the sponsor keeps whatever trust and new money it can scrape together, and the few shareholders who stay in absorb the dilution the redeemed crowd just dodged.

The banker's cut says a lot about the market, too. D. Boral's cash fee here is a flat $805,000 — a bit over 1% of the deal — plus $110,000 in expenses and 150,000 "representative shares," i.e., compensation paid in equity rather than cash. During the SPAC boom, the standard check to an underwriter was on the order of 5.5% of the deal, much of it deferred to closing. Roughly a fifth of that, in cash, with the balance in shares, is the 2026 market talking. The prospectus's own history is more explicit: the unit got sweeter as the filing ground on (the right was raised from one-fifth to one-fourth of a share, and a whole warrant was added in June), and in August the deal was cut from 10 million units to 7.5 million, with the representative shares trimmed at the same time. Issuer, buyer, and banker all renegotiated, and the direction of concessions ran from the middleman toward the buyer.

Why a China-flavored blank check, and why now? Zhang also runs the first Southern Cross vehicle — the same template, a $100 million IPO on Nasdaq in July, also with D. Boral as sole bookrunner. The prospectus says the company "may pursue opportunities in China (including Hong Kong and Macau)" because of its "significant ties to China." "May" is doing a lot of work — nothing here commits the company to any particular geography — but the management, the Cayman wrapper, and the serial structure all point one direction: a Chinese business that wants a U.S. listing without doing a U.S. IPO.

And that route exists right now because of a classification line. In May the SEC approved Nasdaq Rule 5210(l), effective mid-June, which raises the initial listing bar for "China-based companies": IPOs need at least $25 million in firm-commitment proceeds, direct listings are curtailed, and a SPAC combination has to clear a $25 million minimum as well. The rule is written to catch offshore entities that are effectively Chinese. A brand-new Cayman shell with its CEO in New Zealand is not on the wrong side of that line at IPO — it lists as an ordinary $10 unit. The line gets crossed later, if and when the shell finds an operating company to merge with, and the combined company has to face the $25 million gate, the usual listing standards, and China's own outbound-listing regulatory machinery and audit oversight. This is the old China reverse merger, repackaged from a one-off corporate maneuver into a packaged unit sale with a banker's logo on it.

It is worth sitting with what "owning this stock" actually means, because it is a peculiar kind of bet. Before any announcement, you own a money-market position that yields pennies, plus options on a deal that may never come. This is not a company, and the ticker idling around $10 is not mood — it is the trust value showing through. The realistic risk is not "the stock falls 50% for no reason"; that takes a deal announcement with bad terms, or something breaking the trust. The realistic risk is that a deal arrives inside 12 months and you have to decide, quickly, whether to stay in — knowing the sponsor gets paid for closing, not for closing well, and knowing the merger math punishes the minority who stay by not redeeming. And if the 12 months run out, you get roughly your $10 back. That is the entire reason units like this sell at all, and the entire reason the promote, the fees, and the China paperwork are worth reading before you file SCATU under "safe."